Browse

A Utah pilot to renew prescriptions using a bot faced backlash from the state's medical board, which called for an immediate suspension.

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.

Tolebrutinib, which the FDA recently turned back due to safety concerns, received a positive recommendation that positions the therapy for its first regulatory approval.